Format

Send to

Choose Destination
Pediatr Infect Dis J. 2005 Oct;24(10):925-7.

Immunogenicity and safety of inactivated influenza virus vaccine in young children in 2003-2004.

Author information

1
Center for Pediatric Research, Eastern Virginia Medical School, Norfolk, 23510, USA. dkmitchel@chkd.com

Abstract

This study assessed the safety and immunogenicity of a pediatric formulation of the 2003-2004 inactivated, trivalent, split virion influenza vaccine, administered in a 2-dose schedule in healthy children ages 6-36 months, of whom 94% had protective titers (> or =1/40) to at least 1 antigen. The 2003-2004 split virion influenza vaccine was safe and immunogenic in young children.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center